BrainsWay TMS: Pioneering Advances in Treating Late-Life Depression

We are excited to share some groundbreaking news from BrainsWay: the FDA has expanded its clearance for our innovative Deep Transcranial Magnetic Stimulation (Deep TMS) technology to include the treatment of depression in older adults, specifically those aged 68-86 years. This marks a significant milestone, making BrainsWay the only TMS device currently FDA-cleared for this age group.

Addressing a Critical Need

Depression in older adults is a pressing and often underrecognized issue. Late-life depression can severely impact quality of life, exacerbating other medical conditions, and increasing the risk of mortality. Traditional treatment methods, including medications and psychotherapy, are not always effective or well-tolerated in this population due to various factors like comorbidities, polypharmacy, and age-related physiological changes. This underscores the urgent need for alternative, more effective treatment options.

The Power of Deep TMS

Deep TMS (Transcranial Magnetic Stimulation) represents a non-invasive, cutting-edge approach to treating depression. Unlike traditional TMS, Deep TMS penetrates deeper and broader into brain structures, directly stimulating areas associated with mood regulation. This enhanced reach and stimulation provide a more robust and effective treatment for depression, with minimal side effects.

Key Benefits of Deep TMS:

Non-Invasive: No anesthesia or surgery required.
Well-Tolerated: Minimal side effects, especially crucial for older adults.
Effective: Proven to reduce depressive symptoms significantly.

FDA Clearance Expansion: A Game Changer

The recent FDA clearance expansion for BrainsWay’s Deep TMS to treat late-life depression is a monumental step forward. This new indication underscores the safety and efficacy of Deep TMS in treating older adults, who are often underserved by existing treatment modalities. The clearance is based on rigorous clinical trials and a robust body of evidence demonstrating the benefits of Deep TMS for this specific age group.

Why This Matters:

Broader Access: More older adults suffering from depression can now benefit from this advanced treatment.
Enhanced Quality of Life: Effective treatment of depression can significantly improve overall well-being and daily functioning in older adults.
Reduced Healthcare Burden: Better management of depression can lead to fewer hospitalizations and healthcare interventions, easing the burden on caregivers and the healthcare system.

Join Us for the Webinar

To further explore this transformative advancement, Brainsway is hosting a webinar titled “Transforming Late-Life Depression with Deep TMS: Insights and Evidence.” This webinar will provide in-depth insights into the science behind Deep TMS, its clinical applications, and the significant impact it can have on treating late-life depression.

Webinar Details:

Date: Wednesday, June 26
Time: 4:00pm EDT / 1:00pm PDT
Registration: Register for link here

What You Will Learn:

The latest evidence supporting Deep TMS for late-life depression.
Case studies and real-world examples of Deep TMS in action.
Practical insights into implementing Deep TMS in clinical practice.